159 related articles for article (PubMed ID: 24114315)
1. RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women.
Krivokuca AM; Malisic EJ; Dobricic JD; Brotto KV; Cavic MR; Jankovic RN; Tomasevic ZI; Brankovic-Magic MV
Fam Cancer; 2014 Jun; 13(2):173-80. PubMed ID: 24114315
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in cancer susceptibility genes XRCC1, RAD51 and TP53 and the risk of breast cancer in Serbian women.
Krivokuca AM; Cavic MR; Malisic EJ; Rakobradovic JD; Kolarevic-Ivankovic D; Tomasevic ZI; Brankovic-Magic MV
Int J Biol Markers; 2016 Jul; 31(3):e258-63. PubMed ID: 26954070
[TBL] [Abstract][Full Text] [Related]
3. Impact of RAD51 G135C and XRCC1 Arg399Gln polymorphisms on ovarian carcinoma risk in Serbian women.
Malisic EJ; Krivokuca AM; Boljevic IZ; Jankovic RN
Cancer Biomark; 2015; 15(5):685-91. PubMed ID: 26406958
[TBL] [Abstract][Full Text] [Related]
4.
Cavic M; Spasic J; Krivokuca A; Boljevic I; Kuburovic M; Radosavljevic D; Jankovic R
J Clin Pathol; 2019 Jan; 72(1):75-80. PubMed ID: 30467244
[TBL] [Abstract][Full Text] [Related]
5. RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects.
Wang Z; Dong H; Fu Y; Ding H
Breast Cancer Res Treat; 2010 Dec; 124(3):765-9. PubMed ID: 20396943
[TBL] [Abstract][Full Text] [Related]
6. RAD51 genotype and triple-negative breast cancer (TNBC) risk in Polish women.
Smolarz B; Zadrożny M; Duda-Szymańska J; Makowska M; Samulak D; Michalska MM; Mojs E; Bryś M; Forma E; Romanowicz-Makowska H
Pol J Pathol; 2013 Apr; 64(1):39-43. PubMed ID: 23625599
[TBL] [Abstract][Full Text] [Related]
7.
Yazdanpanahi N; Salehi R; Kamali S
J Cancer Res Ther; 2018; 14(3):614-618. PubMed ID: 29893328
[TBL] [Abstract][Full Text] [Related]
8. [Association of polymorphisms of N372H in BRCA2 gene and 135G/C in RAD51 gene and breast cancers].
Hu R; Wei Y; Jiang WJ; Yao WX; Long QM; Zhang JH; Liang Y; Tang XL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 39(6):973-5. PubMed ID: 19253839
[TBL] [Abstract][Full Text] [Related]
9. RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies.
Gao LB; Pan XM; Li LJ; Liang WB; Zhu Y; Zhang LS; Wei YG; Tang M; Zhang L
Breast Cancer Res Treat; 2011 Feb; 125(3):827-35. PubMed ID: 20640595
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in RAD51, XRCC2 and XRCC3 genes of the homologous recombination repair in colorectal cancer--a case control study.
Krupa R; Sliwinski T; Wisniewska-Jarosinska M; Chojnacki J; Wasylecka M; Dziki L; Morawiec J; Blasiak J
Mol Biol Rep; 2011 Apr; 38(4):2849-54. PubMed ID: 21104022
[TBL] [Abstract][Full Text] [Related]
11. RAD51 135G>C substitution increases breast cancer risk in an ethnic-specific manner: a meta-analysis on 21,236 cases and 19,407 controls.
Sekhar D; Pooja S; Kumar S; Rajender S
Sci Rep; 2015 Jun; 5():11588. PubMed ID: 26108708
[TBL] [Abstract][Full Text] [Related]
12. RAD51 135G>C polymorphism and risk of familial breast cancer in a South American population.
Jara L; Acevedo ML; Blanco R; Castro VG; Bravo T; Gómez F; Waugh E; Peralta O; Cabrera E; Reyes JM; Ampuero S; González-Hormazábal P
Cancer Genet Cytogenet; 2007 Oct; 178(1):65-9. PubMed ID: 17889711
[TBL] [Abstract][Full Text] [Related]
13. 135G>C and 172G>T polymorphism in the 5' untranslated region of RAD51 and sporadic endometrial cancer risk in Polish women.
Smolarz B; Samulak D; Michalska M; Góralczyk B; Szyłło K; Lewy J; Sporny S; Kokołaszwili G; Burzyński M; Romanowicz-Makowska H
Pol J Pathol; 2011 Sep; 62(3):157-62. PubMed ID: 22102073
[TBL] [Abstract][Full Text] [Related]
14. RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies.
Yu KD; Yang C; Fan L; Chen AX; Shao ZM
Breast Cancer Res Treat; 2011 Apr; 126(2):365-71. PubMed ID: 20461453
[TBL] [Abstract][Full Text] [Related]
15. Association between polymorphisms of the DNA repair gene RAD51 and ovarian cancer.
Smolarz B; Makowska M; Samulak D; Michalska MM; Mojs E; Romanowicz H; Wilczak M
Pol J Pathol; 2013 Dec; 64(4):290-5. PubMed ID: 24375044
[TBL] [Abstract][Full Text] [Related]
16. TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients.
Nairuz T; Rahman M; Bushra MU; Kabir Y
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2091-2098. PubMed ID: 32711437
[TBL] [Abstract][Full Text] [Related]
17. Association between the RAD51 135 G>C polymorphism and risk of cancer: a meta-analysis of 19,068 cases and 22,630 controls.
Wang W; Li JL; He XF; Li AP; Cai YL; Xu N; Sun SM; Wu BY
PLoS One; 2013; 8(9):e75153. PubMed ID: 24040396
[TBL] [Abstract][Full Text] [Related]
18. Lack of influence of TP53 Arg72Pro and 16bp duplication polymorphisms on risk of breast cancer in Iran.
Gohari-Lasaki S; Gharesouran J; Ghojazadeh M; Montazeri V; Mohaddes Ardebili SM
Asian Pac J Cancer Prev; 2015; 16(7):2971-4. PubMed ID: 25854391
[TBL] [Abstract][Full Text] [Related]
19. 172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant.
Lu J; Wang LE; Xiong P; Sturgis EM; Spitz MR; Wei Q
Carcinogenesis; 2007 May; 28(5):988-94. PubMed ID: 17118968
[TBL] [Abstract][Full Text] [Related]
20. Association between RAD51 135 G/C polymorphism and risk of 3 common gynecological cancers: A meta-analysis.
Zeng X; Zhang Y; Yang L; Xu H; Zhang T; An R; Zhu K
Medicine (Baltimore); 2018 Jun; 97(26):e11251. PubMed ID: 29952992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
